MDCO - The Medicines Company to Announce Fourth-Quarter and Full-Year 2018 Financial Results on February 27
The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, February 27, 2019, at 8:30 a.m. EST to discuss its fourth-quarter and full-year 2018 financial results and operational developments.
The conference call may be accessed by telephone as follows:
| U.S./Canada: |
| (877) 407-0312 |
| International: |
| (201) 389-0899 |
| Conference ID: |
| 13687492 |
A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:
| U.S./Canada: |
| (877) 660-6853 |
| International: |
| (201) 612-7415 |
| Conference ID: |
| 13687492 |
A live audio webcast of the conference call will be available on The Medicines Company Investor Relations website. An archived webcast will be available after the call concludes.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190220005135/en/
Investor Relations
Krishna
Gorti, M.D.
Vice President, Investor Relations
973 290 6122
krishna.gorti@themedco.com